Category: Video | CATIE Blog

INHSU 2022: Global perspectives on the health of people who use drugs

December 13, 2022 • By Christopher Hoy

In October 2022, CATIE attended the 10th International Conference on Health and Hepatitis Care in Substance Users, INHSU 2022, in Glasgow, Scotland. INHSU 2022 is the leading international conference on hepatitis C and the health of people who use drugs. Researchers, frontline service providers, policy-makers, advocates and people with lived and living experience gathered from around the world to share and discuss the latest in research, programs and policy on the health of people who use drugs. We interviewed several Canadian and international attendees to share what they learned at INHSU 2022, as well as their reflections on the future...

Reframing Ontario’s overdose crisis: Addressing inhalation and stimulant use

November 1, 2021 • By Nick Boyce and Netta Kornberg

The overdose crisis in Ontario is often stereotyped as an “opioid injection” crisis. However, data show that significant numbers of overdoses are also being driven by stimulant drug use and inhalation drug use.

Five ways to sustain the hepatitis C elimination efforts in Canada

July 6, 2020 • By Christopher Hoy

This June, CATIE and the Canadian Network on Hepatitis C (CanHepC) co-hosted a webinar on sustaining the hepatitis C response before and after the novel coronavirus disease (COVID-19) pandemic. We invited leaders in the hepatitis C field to explore the challenges that the pandemic has posed for hepatitis C elimination efforts, but also the opportunities that could be leveraged. Here are just five of the ways we can do this:

Where do we go from here?

November 19, 2014 • By Laurie Edmiston

Recently I was asked to speak at an event organized by Alex McClelland and Nicole Greenspan called “Where Do We Go From Here? AIDS Organizing, Services, Bureaucracy & the State.” The event aimed to address a number of questions, including: What are the limits of current community-based practice based on engagement with the state? Are today’s AIDS service organizations (ASOs) adequately resourced and designed to undertake their intended role? Is the role sufficient to address the ongoing and emerging HIV issues that marginalized communities face? Due to state constraints, what are the consequences on advocacy possibilities for ASOs, or ASO...